February 22, 2021August 24, 2022
Enhertu Approved in UK for Inoperable, Advanced Breast Cancer
News
Enhertu (trastuzumab deruxtecan) has been granted conditional approval in the U.K. for the treatment of adults with inoperable or metastatic ... Read more
February 18, 2021February 18, 2021
Phase 2 Trial Will Test IRX-2 Combined With Keytruda, Chemotherapy for TNBC
News
An open-label Phase 2 clinical trial will test the safety and efficacy of IRX-2, an experimental immunology-based cancer therapy, in ... Read more
February 15, 2021February 15, 2021
Tukysa Combo Approved in EU for Advanced HER2-Positive Breast Cancer
News
Seagen’s Tukysa (tucatinib) has been approved by the European Commission (EC) as part of a triple-combination therapy for people with previously ... Read more
February 11, 2021February 11, 2021
Trial Testing AL101 in TNBC Doses First Patient
News
The first participant has been dosed in the Phase 2 clinical trial TENACITY, which is evaluating Ayala Pharmaceuticals‘ investigational therapy ... Read more
February 8, 2021February 8, 2021
‘Overwhelmingly Positive’ Data Halts Endoxifen Phase 2 Trial for Invasive Cancer
News
After promising results from patients enrolled to date, Atossa Therapeutics halted an Australian Phase 2 clinical trial evaluating its investigative ... Read more
February 4, 2021February 4, 2021
Theralink Begins Testing New Biomarker Assay for Breast Cancer Tumors
News
Theralink Technologies announced that it has begun testing its new profiling biomarker assay — a test that could potentially provide ... Read more
February 1, 2021February 1, 2021
US Study Enrolling Women to Help Determine Best Screening Practices
News
A national study is seeking women in the U.S. to help determine the safest and best way to screen for ... Read more
January 28, 2021January 28, 2021
Nonprofit Highlights Importance of Global Teamwork for World Cancer Day
News
In honor of World Cancer Day on Feb. 4, the Breast International Group (BIG) emphasized the importance of wide-scale cooperation ... Read more
January 25, 2021January 25, 2021
Enhertu Approved in EU for Inoperable, Advanced Breast Cancer
News
The European Commission has conditionally approved Enhertu (trastuzumab deruxtecan) for adults in the EU with inoperable or metastatic HER2-positive breast cancer ... Read more
January 21, 2021January 21, 2021
Imagio Imaging System for Breast Cancer Diagnosis Approved by FDA
News
Imagio, Seno Medical Instruments’ non-invasive and radiation-free breast imaging technology, has been approved for commercialization by the Center for Devices and ... Read more
January 18, 2021January 18, 2021
Mindfulness Can Alter Brain’s Perception of Pain in Cancer Survivors
News
Mindfulness can significantly improve brain health and pain perception in breast cancer survivors, according to a small Canadian study. The ... Read more
January 14, 2021January 14, 2021
Genetic Test for Advanced Breast Cancer Launched in EU
News
Roche has launched a diagnostic genetic test to detect mutations in the PIK3CA gene in patients with advanced or metastatic ... Read more

November 9, 2018

Researchers Develop ‘Bio-patch’ to Monitor Post-surgical Success of Breast Reconstruction

News

An international team of researchers has developed a wireless device that can detect early problems after a patient undergoes breast reconstruction surgery. The work, led by Imperial College London in the U.K., ... Read more

November 7, 2018

Phase 2 Trial to Test Keytruda, Tomivosertib Combo in Triple-negative Breast Cancers

News

An upcoming Phase 2 trial will evaluate a combination of the immunotherapies Keytruda (pembrolizumab) and tomivosertib (eFT508) as a treatment for triple-negative breast cancer patients whose disease has spread to other ... Read more

November 6, 2018November 5, 2018

The Dodgers, the Statue of Liberty, Breast Cancer, and Me

A Lump in the Road - A Column by Nancy Brier, Columns

After the fifth inning, I found myself caught off guard. I’d just gone to the kitchen to make popcorn, and when I came back, 50,000 people were standing side ... Read more

November 5, 2018

Ibrance-Faslodex Combo Improves Survival of Advanced Breast Cancer Patients, Phase 3 Trial Shows

News

Adding Pfizer’s Ibrance (palbociclib) to standard treatment Faslodex (fulvestrant) significantly extended the survival of advanced breast cancer patients in a Phase 3 clinical trial, researchers report. Called PALOMA-3, the trial (NCT01942135) specifically ... Read more

November 2, 2018

Processed Meat Consumption Linked to Higher Breast Cancer Risk, Review Study Shows

News

Eating processed meat, such as sausage, ham, and bacon, but not red meat, on a regular basis is associated with a significantly increased risk of breast cancer, a review study ... Read more

October 30, 2018October 26, 2018

Paint the Parking Spot Pink

A Lump in the Road - A Column by Nancy Brier, Columns

Recently, I flew to the Bay Area for a checkup to ensure my cancer is still gone. I perform a ritual every six months: Buy a ticket, pack a suitcase, ... Read more

October 29, 2018

Therapies Given to Women with Advanced Breast Cancer Equally Effective and Safe in Men, Studies Report

News

Current therapies used to treat advanced breast cancer in women are also effective and safe for men with this disease, according to results of three different studies. These findings were ... Read more

October 26, 2018

Tecentriq-Abraxane Prolongs Survival of Advanced Triple-negative Breast Cancer Patients, Study Shows

News

Combining Tecentriq (atezolizumab) with the chemotherapy Abraxane (nab-paclitaxel) extends overall survival, and survival without cancer progression, in patients with triple negative breast cancer (TNBC) whose cancer is locally advanced or ... Read more

October 24, 2018

Sermonix Launches Phase 2 Trial Testing Lasofoxifene in Advanced Breast Cancer Patients with ER Mutations

News

Sermonix is launching a Phase 2 trial to determine if its lead investigational medicine lasofoxifene is better than Faslodex (fulvestrant) at delaying disease progression or death in breast cancer patients who ... Read more

October 23, 2018October 22, 2018

I Wouldn’t Give My Right Arm

A Lump in the Road - A Column by Nancy Brier, Columns

I’m pretty good at handling cosmic injustices — cancer, two burned down houses, my mom’s Alzheimer’s, and my dad’s myasthenia gravis. My kid gets migraines, my husband has gut problems, and my ... Read more

October 22, 2018October 22, 2018

University of Cincinnati Institute Opens Breast and Ovarian Cancer Risk Program

News

With the aim of identifying people at high risk of developing breast and ovarian cancers, and preventing progression in those who are, the University of Cincinnati (UC) Cancer Institute’s Breast ... Read more

October 19, 2018

FDA Approves Talzenna to Treat BRCA-mutated Metastatic Breast Cancer

News

The U.S. Food and Drug Administration (FDA) has approved Pfizer’s Talzenna (talazoparib) for the treatment of HER2-negative advanced breast cancer in adult patients with inherited BRCA mutations. The FDA also stated that patients’ eligibility for ... Read more

Enhertu Approved in UK for Inoperable, Advanced Breast Cancer

Phase 2 Trial Will Test IRX-2 Combined With Keytruda, Chemotherapy for TNBC

Tukysa Combo Approved in EU for Advanced HER2-Positive Breast Cancer

Trial Testing AL101 in TNBC Doses First Patient

‘Overwhelmingly Positive’ Data Halts Endoxifen Phase 2 Trial for Invasive Cancer

Theralink Begins Testing New Biomarker Assay for Breast Cancer Tumors

US Study Enrolling Women to Help Determine Best Screening Practices

Nonprofit Highlights Importance of Global Teamwork for World Cancer Day

Enhertu Approved in EU for Inoperable, Advanced Breast Cancer

Imagio Imaging System for Breast Cancer Diagnosis Approved by FDA

Mindfulness Can Alter Brain’s Perception of Pain in Cancer Survivors

Genetic Test for Advanced Breast Cancer Launched in EU